Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/ Formoterol Fumarate Metered Dose Inhaler (BGF MDI)

被引：0
|
作者：
Rabe, K. F. [1 ,2 ]
Fabbri, L. M. [3 ]
Martinez, F. J. [4 ]
Ferguson, G. T. [5 ]
Bourne, E. [6 ]
Darken, P. [6 ]
DeAngelis, K. [6 ]
Aurivillius, M. [7 ]
Reisner, C. [7 ]
Dorinsky, P. [6 ]
机构：
[1] Lungenclin Grosshansdorf GmbH, Zentrum Pneumol & Thoraxchirurg, Grosshansdorf, Germany
[2] Deutsch Zentrum Lungenforsch Dzl, Airway Res Ctr North Arcn, Giessen, Germany
[3] Sahlgrens Univ Hosp, Gothenburg, Sweden
[4] Joan & Sanford I Weill Dept Med, New York, NY USA
[5] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[6] Pearl Astrazeneca, Durham, NC USA
[7] Astrazeneca, Cambridge, England
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403160
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P488
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Glycopyrrolate/formoterol fumarate metered dose inhaler for maintenance-naïve patients with chronic obstructive pulmonary disease: a post-hoc analysis of the randomized PINNACLE trials
    Jinping Zheng
    Jin-fu Xu
    Martin Jenkins
    Pryseley Nkouibert Assam
    Lijiao Wang
    Brian J. Lipworth
    Respiratory Research, 21
  • [42] Late Breaking Abstract - Impact of eosinophil levels on lung function and exacerbation benefits with co-suspension delivery technology budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) in COPD (KRONOS study subgroup analysis)
    Fabbri, Leonardo Michele
    Rabe, Klaus F.
    Martinez, Fernando J.
    Ferguson, Gary T.
    Wang, Chen
    Ichinose, Masakazu
    Bourne, Eric
    Ballal, Shaila
    Darken, Patrick
    Deangelis, Kiernan
    Aurivillius, Magnus
    Dorinsky, Paul
    Reisner, Colin
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Moderate Chronic Obstructive Pulmonary Disease in the ETHOS Study
    Ferguson, G. T.
    Rabe, K. F.
    Singh, D.
    Jenkins, M.
    Patel, M.
    Aurivillius, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [44] Safety and Efficacy of Budesonide-Glycopyrrolate-Formoterol Fumarate for COPD in Black or African-American Patients: A Post-Hoc Subgroup Analysis of the ETHOS Study
    Han, M. K.
    Jenkins, M.
    Carstens, D.
    Patel, M.
    Feigler, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [45] Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies
    Martinez, Fernando J.
    Lipworth, Brian J.
    Rabe, Klaus F.
    Collier, David J.
    Ferguson, Gary T.
    Sethi, Sanjay
    Feldman, Gregory J.
    O'Brien, Gerald
    Jenkins, Martin
    Reisner, Colin
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [46] Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies
    Fernando J. Martinez
    Brian J. Lipworth
    Klaus F. Rabe
    David J. Collier
    Gary T. Ferguson
    Sanjay Sethi
    Gregory J. Feldman
    Gerald O’Brien
    Martin Jenkins
    Colin Reisner
    Respiratory Research, 21
  • [47] Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial
    Rabe, Klaus F.
    Martinez, Fernando J.
    Singh, Dave
    Trivedi, Roopa
    Jenkins, Martin
    Darken, Patrick
    Aurivillius, Magnus
    Dorinsky, Paul
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2021, 15
  • [48] Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
    Chen, Rongchang
    Zhong, Nanshan
    Wang, Hao-Yan
    Zhao, Li
    Mei, Xiaodong
    Qin, Zhiqiang
    Huang, Juan
    Assam, Pryseley N.
    Maes, Andrea
    Siddiqui, Shahid
    Martin, Ubaldo J.
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 43 - 56
  • [49] Exacerbation benefit by blood eosinophil counts with budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial: a subgroup analysis
    Rabe, Klaus F.
    Martinez, Fernando J.
    Ferguson, Gary T.
    Wang, Chen
    Singh, Dave
    Wedzicha, Jadwiga A.
    Trivedi, Roopa
    St Rose, Earl
    Ballal, Shaila
    Mclaren, Julie
    Darken, Patrick
    Aurivillius, Magnus
    Reisner, Colin
    Dorinsky, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
    Martinez, Fernando J.
    Rabe, Klaus F.
    Lipworth, Brian J.
    Arora, Samir
    Jenkins, Martin
    Martin, Ubaldo J.
    Reisner, Colin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 99 - 106
12345